HomeMy WebLinkAboutORD NO 4823ORDINANCE NO. 4823
ORDINANCE ENACTING
BAKERSFIELD MUNICIPAL
UNREGULATED CHEMICALS.
CHAPTER 9.13 OF THE
CODE RELATING TO
WHEREAS, the Legislative and Litigation Committee requested the City
Attorney's office draft an ordinance banning use, possession and /or selling of
unregulated chemicals; and
WHEREAS, psychoactive drugs and similar products such as bath salts and
spice are commonly comprised of unregulated chemicals; and
WHEREAS, these unregulated chemicals have been documented to
cause hallucinations, agitation, psychosis, aggression, suicidal and homicidal
tendencies, cannibalism, and death; and
WHEREAS, while state and federal laws and regulations prohibit some
psychoactive drugs, the makers of these drugs continually alter the composition
of the compounds and unregulated chemicals so as to escape the purview of
laws and regulations; and
WHEREAS, the purpose and intent of this Chapter is to provide the City with
reasonable measures to address the dangers to the community posed by
chemicals that are not fully regulated by state or federal law.
NOW, THEREFORE, BE IT ORDAINED by the City Council of the City of
Bakersfield as follows:
SECTION 1.
The foregoing recitals, incorporated herein, are found to be true and
correct.
SECTION 2.
Chapter 9.13 of the Bakersfield Municipal Code is hereby enacted to read
as follows:
Title 9 PUBLIC PEACE, MORALS AND WELFARE
SACOUNCIL \Ords\ 15- 16 \9.13UnregulatedChemicals.docx
-- Page 1 of 9 Pages --
�gPK4 9
r �
U �
ORIGINAL
III. Offenses Against Public Decency
Chapter 9.13 UNREGULATED CHEMICALS
Sections:
9.13.010 Definitions
9.13.020 Acts Prohibited
9.13.030 Penalties
9.13.040 Severability
9.13.010 Definitions.
A. "Person" means any individual, partnership, corporation, or
association of any nature whatsoever.
B. "Unregulated Chemicals" means the following chemical,
compound, or derivative not approved by the Federal Food and Drug
Administration:
(1) Adamantoylindoles or adamantoylindazoles, which includes
adamantyl carboxamide indoles and adamantyl carboxamide indazoles, or
any compound structurally derived from 3- (1- adamantoyl)indole, 3 -(1-
adamantoyl)indazole, 3- (2- adamantoyl)indole, N- (1- adamantyl) -1 H- indole -3-
carboxamide, or N- (1- adamantyl) -1 H- indazole -3- carboxamide by substitution at
the nitrogen atom of the indole or indazole ring with alkyl, haloalkyl, alkenyl,
cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl, 1-(N- methyl -2-
piperidinyl)methyl, 2- (4- morpholinyl) ethyl, or 1-( N- methyl- 2- pyrrolidinyl)methyl, 1-
(N- methyl- 3- morpholinyl)m ethyl, or (tetra h ydropyra n-4-yl) m ethyl group, whether
or not further substituted in the indole or indazole ring to any extent and whether
or not substituted in the adamantyl ring to any extent, including, but not limited
to, 2NE1, 5F- AKB -48, AB -001, AKB -48, AM -1248, JWH -018 adamantyl
carboxamide, STS -135.
(2) Benzoylindoles, which includes any compound structurally derived
from a 3- (benzoyl)indole structure with substitution at the nitrogen atom of the
indole ring with alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl,
cycloalkylmethyl, cycloalkylethyl, 1 -(N- methyl- 2- piperidinyl)methyl, 2 -(4-
morpholinyl) ethyl, or 1-( N- methyl- 2- pyrrolidinyl)methyl, 1-(N- methyl -3-
morpholinyl)methyl, or (tetra h yd ro pyra n-4-yl) m ethyl group, whether or not
further substituted in the indole ring to any extent and whether or not substituted
in the phenyl ring to any extent, including, but not limited to, AM -630, AM -661,
AM -679, AM -694, AM -1241, AM -2233, RCS -4, WIN 48,098 (Pravadoline).
S: \COUNCIL \Ords\ 15- 16 \9.13UnregulatedChemicals.docx
o�.�AKF9
s
-- Page 2 of 9 Pages -- m
L) o
ORIGINAL
(3) Cyclohexylphenols, which includes any compound structurally derived
from 2- (3- hydroxycyclohexyl) phenol by substitution at the 5- position of the
phenolic ring by alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl,
cycloalkylmethyl, cycloalkylethyl, 1 -(N- methyl- 2- piperidinyl)methyl, 2 -(4-
morpholinyl) ethyl, or 1-( N- methyl- 2- pyrrolidinyl)methyl, 1-(N- methyl -3-
morpholinyl)methyl, or (tetra h ydro pyra n-4-yl) m ethyl group, whether or not
further substituted in the cyclohexyl ring to any extent, including, but not limited
to, CP 47,497, CP 55,490, CP 55,940, CP 56,667, cannabicyclohexanol.
(4) Cyclopropanoylindoles, which includes any compound structurally
derived from 3- (cyclopropylmethanoyl)indole, 3-
(cyclopropylmetha none) indole, 3- (cyclobutylmetha none) indole or 3-
(cyclopentylmetha none) indole by substitution at the nitrogen atom of the
indole ring, whether or not further substituted in the indole ring to any extent,
whether or not substituted on the cyclopropyl, cyclobutyl, or cyclopentyl rings to
any extent.
(5) Naphthoylindoles, which includes any compound structurally derived
from 3- (1- naphthoyl)indole or 1 H- indol- 3- yl- (1- naphthyl)methane by substitution
at the nitrogen atom of the indole ring by alkyl, haloalkyl, cyanoalkyl,
hydroxyalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N- methyl -2-
piperidinyl)methyl, 2- (4- morpholinyl) ethyl group, 1-(N- methyl -2-
pyrrolidinyl)methyl, 1 -(N- methyl- 3- morpholinyl)methyl, or (tetra hydropyran-4-
yl)methyl group, whether or not further substituted in the naphthyl ring to any
extent, including, but not limited to, AM -678, AM -1220, AM -1221, AM -1235, AM-
2201, AM -2232, EAM -2201, JWH -004, JWH -007, JWH -009, JWH -011, JWH -015, J W H-
016, JWH -018, JWH -019, JWH -020, JWH -022, JWH -046, JWH -047, JWH -048, J W H-
049, JWH -050, JWH -070, JWH -071, JWH -072, JWH -073, JWH -076, JWH -079, J W H-
080, JWH -081, JWH -082, JWH -094, JWH -096, JWH -098, JWH -1 16, JWH -120, JWH -
122, JWH -148, JWH -149, JWH -164, JWH -166, JWH -180, JWH -181, JWH -182, JWH -
189, JWH -193, JWH -198, JWH -200, JWH -210, JWH -211, JWH -212, JWH -213, JWH -
234, JWH -235, JWH -236, JWH -239, JWH -240, JWH -241, JWH -242, JWH -258, J W H-
262, JWH -386, JWH -387, JWH -394, JWH -395, JWH -397, JWH -398, JWH -399, J W H-
400, JWH -412, JWH -413, JWH -414, JWH -415, JWH -424, MAM -2201, WIN 55,212.
(6) Naphthoylnaphthalenes, which includes any compound structurally
derived from naphthalene -1 -yl- (naphthalene -1 -yl) methanone with substitutions
on either of the naphthalene rings to any extent, including, but not limited to,
CB -13.
(7) Naphthoylpyrroles, which includes any compound structurally derived
from 3- (1- naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole
ring by alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl, cycloalkylmethyl,
S: \COUNCIL \Ords\ 15- 16 \9.13UnregulatedChemicals.docx
o�,bAKF9.�
s
-- Page 3 of 9 Pages -- o
ORIGINAL
cycloalkylethyl, 1- (N- methyl- 2- piperidinyl)methyl, 2- (4- morpholinyl) ethyl, or 1 -(N-
methyl- 2- pyrrolidinyl)m ethyl, 1 -(N- methyl- 3- morpholinyl)methyl, or
(tetra hydropyran- 4- yl)methyl group, whether or not further substituted in the
pyrrole ring to any extent and whether or not substituted in the naphthyl ring to
any extent, including, but not limited to, JWH -030, JWH -031, JWH -145, JWH -146,
JWH -147, JWH -150, JWH -156, JWH -243, JWH -244, JWH -245, JWH -246, JWH -292,
JWH -293, JWH -307, JWH -308, JWH -309, JWH -346, JWH -348, JWH -363, JWH -364,
JWH -365, JWH -367, JWH -368, JWH -369, JWH -370, JWH -371, JWH -373, JWH -392.
(8) Naphthylmethylindenes, which includes any compound containing a
naphthylideneindene structure or which is structurally derived from 1 -(1-
naphthylmethyl)indene with substitution at the 3- position of the indene ring by
alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl, cycloalkylmethyl,
cycloalkylethyl, 1- (N- methyl- 2- piperidinyl)methyl, 2- (4- morpholinyl) ethyl, or 1 -(N-
methyl-2-pyrrolidinyl)methyl, 1 -(N- methyl- 3- morpholinyl)methyl, or
(tetra hydropyran- 4- yl)methyl group, whether or not further substituted in the
indene ring to any extent and whether or not substituted in the naphthyl ring to
any extent, including, but not limited to, JWH -171, JWH -176, JWH -220.
(9) Naphthylmethylindoles, which includes any compound structurally
derived from an H- indol- 3- yl -(1- naphthyl) methane by substitution at the nitrogen
atom of the indole ring by alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl,
cycloalkylmethyl, cycloalkylethyl, 1 -(N- methyl -2- piperidinyl)methyl, 2 -(4-
morpholinyl) ethyl, or 1-( N- methyl- 2- pyrrolidinyl)methyl, 1-(N- methyl -3-
morpholinyl)methyl, or (tetra hydropyran- 4- yl)methyl group, whether or not
further substituted in the indole ring to any extent and whether or not substituted
in the naphthyl ring to any extent, including, but not limited to, JWH -175, JWH -
184, JWH -185, JWH -192, JWH -194, JWH -195, JWH -196, JWH -197, JWH -199.
(10) Phenylacetylindoles, which includes any compound structurally
derived from 3- phenylacetylindole by substitution at the nitrogen atom of the
indole ring with alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl,
cycloalkylmethyl, cycloalkylethyl, 1 -(N- methyl- 2- piperidinyl)methyl, 2 -(4-
morpholinyl) ethyl, or 1-( N- methyl- 2- pyrrolidinyl)methyl, 1-(N- methyl -3-
morpholinyl)methyl, or (tetra hydro, pyran- 4- yl)methyl group, whether or not
further substituted in the indole ring to any extent and whether or not substituted
in the phenyl ring to any extent, including, but not limited to,
cannabipiperidietha none, JWH -167, JWH -201, JWH -202, JWH -203, JWH -204, JWH -
205, JWH -206, JWH -207, JWH -208, JWH -209, JWH -237, JWH -248, JWH -249, J W H-
250, JWH -251, JWH -253, JWH -302, JWH -303, JWH -304, JWH -305, JWH -306, J W H-
31 1, JWH -312, JWH -313, JWH -314, JWH -315, JWH -316, RCS -8.
S: \COUNCIL \Ords\ 15- 16 \9.13UnregulatedChemicals.docx
-- Page 4 of 9 Pages --
o`` g AKF9�
r-- m
r
U O
ORIGINAL
(11) Quinolinylindolecarboxylates, which includes any compound
structurally derived from quinolin- 8 -yl -1 H- indole- 3- carboxylate by substitution at
the nitrogen atom of the indole ring with alkyl, haloalkyl, benzyl, halobenzyl,
alkenyl, haloalkenyl, alkoxy, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl,
cycloalkylethyl, (N -m ethyl piperidin- 2- yl)aIkyl, (4- tetrahydropyran)alkyl, or 2 -(4-
morpholinyl)alkyl, whether or not further substituted in the indole ring to any
extent, whether or not substituted in the quinoline ring to any extent, including,
but not limited to, BB -22, 5- Fluoro- PB -22, PB -22.
(12) Tetra methylcyclopropanoylindoles, which includes any compound
structurally derived from 3- tetramethylcyclopropanoylindole, 3 -(1-
tetra methylcyclopropyl) indole, 3-( 2, 2, 3, 3- tetramethylcyclopropyl)indole or 3-
(2,2,3,3-tetramethylcyclopropylcarbonyl)indole with substitution at the nitrogen
atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl,
cycloalkylmethyl, cycloalkylethyl, 1- (N- methyl- 2- piperidinyl)methyl, 2 -(4-
morpholinyl) ethyl, 1-( N- methyl- 2- pyrrolidinyl)methyl, 1-(N- methyl -3-
morpholinyl)methyl, or (tetra h ydro pyra n-4-yl) m ethyl group whether or not further
substituted in the indole ring to any extent and whether or not substituted in the
tetra methylcyclopropanoyl ring to any extent, including, but not limited to, 5-
bromo -UR -144, 5- chloro -UR -144, 5- fluoro -UR -144, A- 796,260, A- 834,735, AB -034,
UR -144, XLR11.
(13) Tetra methylcyclo pro pan e- thiazole carboxamides, which includes any
compound structurally derived from 2, 2,3,3- tetramethyl- N- (thiazol -2-
ylidene)cyclopropanecarboxamide by substitution at the nitrogen atom of the
thiazole ring by alkyl, haloalkyl, benzyl, halobenzyl, alkenyl, haloalkenyl, alkoxy,
cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl, (N -m ethyl piperidin -2-
yl)alkyl, (4- tetrahydropyran)alkyl, or 2- (4- morpholinyl)alkyl, whether or not further
substituted in the thiazole ring to any extent, whether or not substituted in the
tetra methyl cyclopropyl ring to any extent, including, but not limited to, A-
836,339.
(14) Unclassified synthetic cannabinoids, which includes all of the
following:
(a) AM -087, (6aR,IOaR)-3-(2- methyl- 6- bromohex- 2 -yl)- 6,6,9- trimethyl-
6a,7, l 0, l 0a- tetrahydrobenzo[c] chromen -1 -ol.
(b) AM -356, methanandamide, including (5Z,8Z,1 1 Z,14Z) -N -[(1 R)-2- hydroxy-
1- methylethyl] icosa- 5,8,11,14- tetraenamide and arachidonyl-l'- hydroxy -2'-
propylamide.
S: \COUNCIL \Ords\ 15- 16 \9.13UnregulatedChemicals.docx
-- Page 5 of 9 Pages --
o``gAKF9
> T �
r— m
U r Cy
ORIGINAL
(c) AM -411, (6aR, l OaR)- 3- (1- adamantyl)- 6,6,9 - trimethyl -6a,7, l 0,1 Oa-
tetra hydrobenzo[c]chromen -1 -ol.
(d) AM -855, (4aR,12bR)-8- hexyl- 2,5,5 - trimethyl- 1,4,4a,8,9,10,11,12b-
octahydronaphtho [3,2- c]isochromen- l2 -ol.
(e) AM -905, (6aR,9R,IOaR)-3-[(E)-hept-l- enyl] -9- (hydroxymethyl) -6,6-
dimethyl- 6a,7,8,9,10, l Oa -hexa hydro benzo [c] chromen- l -ol.
(f) AM -906, (6aR,9R,lOaR)-3-[(Z)-hept-l- enyl] -9- (hydroxymethyl) -6,6-
dimethyl- 6a,7,8,9,10, l Oa- hexahydrobenzo[c]chromen -1 -ol.
(g) AM -2389, (6aR,9R,1 OaR) -3 -(1- hexyl- cyclobut- l- yl)- 6a,7,8,9, l 0, l 0a-
hexahydro-6,6- dimethyl -6H- dibenzo[b,d]pyran -1,9 diol.
(h) BAY 38 -7271, (-)-(R)-3-(2-Hydroxymethylindanyl-4- oxy)phenyl- 4,4,4-
trifluorobutyl- 1 - sulfonate.
(i) CP 50,556 -1, Levonantradol, including 9- hydroxy -6- methyl -3 -[5-
phenylpentan- 2- yl]oxy- 5,6,6a,7,8,9, l 0, l Oa- octahydrophenanthridin- l- yl]acetate;
[(6S,6aR,9R, IOaR)-9- hydroxy -6- methyl- 3- [(2R) -5- phenylpentan- 2- yl]oxy-
5,6,6a,7,8,9,10,1Oa- octahydrophenanthridin- l- yl]acetate; and [9- hydroxy -6-
methyl-3-[5- phenylpentan -2- yl]oxy- 5,6,6a,7,8,9,10,1 Oa-octahydrophenanthridin-
1-yl]acetate.
(j) HU -210, including (6aR,IOaR) -9 -( hydroxym ethyl) -6,6- dimethyl -3 -(2-
m ethyl octan- 2- yl)- 6a,7,10,1 Oa-tetra hydro benzo[c] chromen -1 -ol; [(6aR,lOaR) -9-
( hydroxym ethyl) -6,6- dimethyl -3 -(2- methyl octan-2-yl)-6a,7,10,1 Oa-
tetra hydrobenzo[c]chromen -1 -ol and 1,1- Dimethylheptyl -1 1-
hydroxytetrahydrocannabinol.
(k) HU -211, Dexanabinol, including (6aS, l OaS)-9- (hydroxym ethyl) -6,6-
dim ethyl-3-(2- methyloctan- 2- yl)- 6a,7,10,1 Oa- tetrahydrobenzo[c]chromen -1 -ol
and (6aS, l OaS) -9- (hydroxymethyl) -6,6- dimethyl- 3-(2- m ethyl octan- 2 -yl)-
6a,7, l 0,1 Oa- tetrahydrobenzo[c] chromen -1 -ol.
(1) HU -243, 3- dimethylheptyl -1 1- hydroxyhexahydrocannabinol.
(m) HU -308, [(91 R,2R,5R)-2-[2,6-dimethoxy-4-(2- methyloctan- 2- yl)phenyl]-
7,7- dimethyl- 4- bicyclo[3.1.1 ] hept -3 -enyl] methanol.
(n) HU -331, 3- hydroxy -2 -[(1 R,6R)-3- methyl- 6- (1- methylethenyl) -2-
cyclohexen- 1- yl]- 5- pentyl -2,5- cyclohexadiene -1,4- dione.
S: \COUNCIL \Ords\ 15- 16 \9.13UnregulatedChemicals.docx
-- Page 6 of 9 Pages --
o`` 0 A K, 9q
U r
0
ORIGINAL.
(o) HU -336, (6aR,l OaR)- 6,6,9- trimethyl- 3- pennyl- 6a,7,10,10a- tetrahydro -1 H-
benzo[c]chromene- 1,4(6H)- dione.
(p) JTE -907, N-(benzo1[1,3]dioxol-5-ylm ethyl) -7- methoxy- 2- oxo- 8- pentyloxy-
1,2- dihydroquinoline -3- carboxamide.
(q) JWH -051, ((6aR, I OaR)-6,6- dimethyl- 3-( 2- methyloctan- 2- yl)- 6a,7,10,10a-
tetrahydrobenzo [c]chromen- 9- yl)methanol.
(r) JWH -057 (6aR,lOaR)-3-(1,l-dimethylheptyl)-6a,7,10,10a- tetrahydro- 6,6,9-
trimethyl-6H- Dibenzo [b,d] pyran.
(s) JWH -133 ( 6aR, l0aR)- 3-( 1,1- Dimethylbutyl)- 6a,7,10,10a- tetrahydro -6,6,9 -
trimethyl-6H- dibenzo [b,d] pyran.
(t) JWH -359, (6aR,IOaR)- 1- methoxy- 6,6,9 - trim ethyl- 3- [(2R)- 1,1,2-
trimethylbutyl]- 6a, 7, 10, 10a- tetrahydrobenzo[c]chromene.
(u) URB -597 [3- (3- carbamoyl phenyl) phenyl] -N- cyclohexylcarbamate.
(v) URB -602 [1,1'- Biphenyl]- 3- yl- carbamic acid, cyclohexyl ester; OR
cyclohexyl [1,1'- biphenyl]- 3- ylcarbamate.
(w) URB -754 6- methyl- 2- [(4- methyl phenyl) amino] - 4H -3,1- benzoxazin -4 -one.
(x) URB- 9373' - carbamoyl -6- hydroxy- [1,1'- biphenyl] -3 -y1
cyclohexylcarba mate.
(y) WIN 55,212 -2, including (R)-(+)-[2,3- dihydro -5- methyl -3 -(4-
morpholinylmethyl) pyrrolo [ 1,2,3 -de] -1,4- benzoxazin- 6- yl] -1-
napthalenylmethanone and [2,3- Dihydro -5- methyl -3 -(4-
morpholinylmethyl) pyrrolo [(1,2,3-de)-1,4- benzoxazin- 6- yl] -1-
napthalenylmethanone.
(15) Unless specifically excepted, or contained within a pharmaceutical
product approved by the United States Food and Drug Administration, any
substance, including its salts, isomers, esters, or ethers, and salts of isomers, esters,
or ethers whenever the existence of such salts, isomers, esters, or ethers, and salts
of isomers, esters, or ethers is- possible, that is structurally derived from 2- amino -1 -
phenyl -l- propanone by modification in one of the following ways:
S: \COUNCIL \Ords\ 15- 16 \9.13UnregulatedChemicals.docx
-- Page 7 of 9 Pages --
AKF9�
f-- m
U r
O
ORIGINAL
(a) By substitution in the phenyl ring to any extent with alkyl, alkoxy,
alkylenedioxy, haloalkyl, or halide substituents, whether or not further substituted
in the phenyl ring by one or more other univalent substituents.
(b) By substitution at the 3- position with an alkyl substituent.
(c) By substitution at the nitrogen atom with alkyl or dialkyl groups, or by
inclusion of the nitrogen atom in a cyclic structure.
9.13.020 Acts Prohibited.
A. It is unlawful for any person to use any unregulated chemical within
the City of Bakersfield.
B. It is unlawful for any person to possess any unregulated chemical
within the city of Bakersfield.
C. It is unlawful for any person to provide, distribute, or sell any
unregulated chemical within the City of Bakersfield.
D. It is unlawful for any person to possess, with the intent to sell, any
unregulated chemical within the City of Bakersfield.
9.13.030 Penalties.
Any person who violates any provision of this chapter is subject to any and
all penalties subject to Title 1 section 1.40.010 of the Bakersfield Municipal Code,
or any other manner permissible by law.
9.13.040 Severability.
If any section, subsection, sentence, clause or phrase of this chapter is for
any reason held to be invalid or unconstitutional, the decision shall not affect
the validity of the remaining portions of the chapter. The city council hereby
declares that it would have passed the ordinance codified in this chapter, and
each section, subsection, sentence, clause, and phrase thereof, irrespective of
the fact that any one or more sections, subsections, sentences, clauses, or
phrases be declared invalid under law.
S: \COUNCIL \Ords\ 15- 16 \9.13UnregulatedChemicals.docx
-- Page 8 of 9 Pages --
�gAKF9
c� l'-"
m
F- r
'v o
ORIGINAL
SECTION 2.
This Ordinance shall be posted in accordance with the Bakersfield
Municipal Code and shall become effective thirty (30) days after the date of its
passage.
I HEREBY CERTIFY that the foregoing Ordinance was passed and adopted
by the Council of the City of Bakersfield at a regular meeting thereof held on
JUL 2 2 2015 , by the following vote:
4
ABSTAIN
ABSENT:
APPROVED
✓ ✓ ✓ ✓ ✓ ✓ ✓
COUNCILMEMBER RIVERA, MAXWELL, WEIR, SMITH, HANSON, SULLIVAN, PARLIER
COUNCILMEMBER N%V-%L,
COUNCILMEMBER
COUNCILMEMBER
JUL 2 2 2015
ROBERTA GAFFORD, C
CITY CLERK and EX OFFI 10 CLERK of the
Council of the City of Bakersfield
APPROVED AS TO FORM:
VIRGINIA GENNARO
City Attorney
By: O / -,�L
TH
THOMAS GEDDES
Associate City Attorney
TG:Isc
-- Page 9 of 9 Pages --
o``gAKF9�
U O
ORIGINAL
AFFIDAVIT OF POSTING DOCUMENTS
STATE OF CALIFORNIA)
) ss.
County of Kern )
ROBERTA GAFFORD, being duly sworn, deposes and says:
That she is the duly appointed, acting and qualified City Clerk of the City of Bakersfield;
and that on the 4th day of August, 2015 she posted on the Bulletin Board at City Hall, a
full, true and correct copy of the following: Ordinance No. 4823, passed by the
Bakersfield City Council at a meeting held on the 22nd day of July, 2015 and entitled:
ORDINANCE ENACTING CHAPTER 9.13 OF THE BAKERSFIELD
MUNICIPAL CODE RELATING TO UNREGULATED CHEMICALS.
ROBERTA GAFFORD
City Clerk and Ex Officio of the
Council of the Citv of Bakersfield
ZWEu-
p1mapArAffiNg
SAD0CUMENl1F0RMSW0P.0RD.wpd
gAIQ9
o
~ m
U �
b
ORIGINAL